Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.29 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | 1 pathway; mostly other | 0.30 |
No case: the score is under the bar. Receipt 1356
Sealed predictions
- SLC12A4 in dopamine neurons, braak-0.16 (p 0.672) → -0.69 (p 0.041)receipt 1363
Swarm cases
receipt 1363: SLC12A4 in dopamine neurons, braak
- power
- full sample -0.42 (p 0.084, n 18), 95% CI -0.74 to +0.06. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.48 (p 0.044, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.67 (p 0.0024, n 18). not the mix.
- skeptic
- leave-one-out range -0.52 to -0.35, sign flips 0; without severely affected donors -0.42 (p 0.084, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SLC12A4 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts